Data / Form D filings / Theriva Biologics, Inc.
Theriva Biologics, Inc.: Form D filings
Theriva Biologics, Inc., a biotechnology company in Rockville, MD, filed 6 Form D notices with the SEC between 2012 and 2025. The latest, on October 24, 2025, reports $13.1 million sold of a $13.1 million offering to 10 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 9605 MEDICAL CENTER DRIVE, SUITE 270, Rockville, MD, 20850
- Phone
- (301) 417-4364
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Nevada
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 894158
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 24, 2025 | New notice | $13,109,494 | $13,109,494 | 10 | Oct 17, 2025 | sec.gov | |
| Aug 4, 2022 | New notice | $3,000,000 | $3,000,000 | 1 | Jul 29, 2022 | sec.gov | |
| Mar 21, 2022 | New notice | $1,467,502 | $1,467,502 | 4 | Mar 10, 2022 | sec.gov | |
| Sep 13, 2017 | New notice | $12,000,000 | $12,000,000 | 1 | Sep 11, 2017 | sec.gov | |
| Nov 5, 2012 | New notice | $10,800,000 | $10,800,000 | 22 | Oct 30, 2012 | sec.gov | |
| Oct 22, 2012 | New notice | $7,637,252 | $7,637,252 | 1 | Oct 16, 2012 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Jeffrey J. Kraws | Director | |
| Jeffrey A. Wolf | Director | |
| John J. Monahan | Director | |
| Steven A. Shallcross | Executive Officer, Director |
Other biotechnology companies in Maryland that filed recently
- Accufy Diagnostics, Inc. $2 million · Oct 28, 2026
- OS Therapies Inc $7.2 million · Oct 23, 2026
- Kaigene, Inc. $55 million · Oct 14, 2026
- Templar Nova, Inc. $7 million · Oct 7, 2026
- Monocacy Therapeutics Inc. $25,000 · Oct 7, 2026
- Seraxis Holdings, Inc. $10 million · Sep 24, 2026
Every Form D from the week of Oct 20, 2025 · All recent filings in Maryland · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Theriva Biologics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.